Results 191 to 200 of about 161,044 (231)

The expanding clinical spectrum of autoinflammatory diseases with NOD2 variants: a case series and literature review. [PDF]

Front Immunol
Karamanakos A, Vougiouka O, Sapountzi E, Venetsanopoulou AI, Tektonidou MG, Germenis AE, Sfikakis PP, Laskari K.   +7 more
europepmc   +1 more source

Patient Experiences and Challenges in the Management of Autoinflammatory Diseases-Data from the International FMF & AID Global Association Survey. [PDF]

J Clin Med
Rech J, Schett G, Tufan A, Kuemmerle-Deschner JB, Özen S, Tascilar K, Geck L, Krickau T, Cohen E, Welzel T, Kuehn M, Vetterli M.   +11 more
europepmc   +1 more source

Bypassing PELO-mediated ATPase activation of the NLR is a common pathogenic cause of NLR-associated autoinflammatory diseases. [PDF]

Cell Mol Immunol
Wu X, Yang ZH, Zheng Y, Wu J, Han J.
europepmc   +1 more source

Identifying high-risk neurological phenotypes in adult-onset classic monogenic autoinflammatory diseases: when should neurologists consider testing? [PDF]

BMC Neurol
Silva GD, Mahler JV, da Silva Junior SRP, Mendonça LO, de Sá Barreto Lima PLG, Nóbrega PR, Kok F, Freua F.   +7 more
europepmc   +1 more source

3D clustering of gene expression data from systemic autoinflammatory diseases using self-organizing maps (Clust3D). [PDF]

Comput Struct Biotechnol J
Papagiannopoulos OD, Pezoulas VC, Papaloukas C, Fotiadis DI.   +3 more
europepmc   +1 more source

Autoinflammatory diseases

, 2012
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Update on autoinflammatory diseases

Current Opinion in Rheumatology, 2023
Purpose of review Although the concept of systemic autoinflammatory diseases (SAIDs) is still very young, our knowledge about them is exponentially growing. In the current review, we aim to discuss novel SAIDs and autoinflammatory pathways discovered in the last couple of years. Recent findings
Kosar Asna, Ashari, Jonathan S, Hausmann, Fatma, Dedeoglu   +2 more
openaire   +2 more sources

Autoinflammatory diseases

Best Practice & Research Clinical Rheumatology, 2008
Autoinflammatory diseases (AIDs) are illnesses caused by primary dysfunction of the innate immune system. Proteins that are mutated in AIDs mediate the regulation of NFkappaB activation, cell apoptosis, and IL-1beta secretion through cross-regulated and sometimes common signaling pathways.
Touitou, I., Kone-Paut, I.
openaire   +2 more sources

Autoinflammatory diseases

Immunology Letters, 2014
Autoinflammatory diseases represent an expanding spectrum of genetic and non-genetic inflammatory diseases characterized by recurrent episodes of fever and systemic inflammation affecting the eyes, joints, skin, and serosal surfaces. Thus, these syndromes are recognized as disorders of innate immunity.
openaire   +3 more sources

Updates on autoinflammatory diseases

Current Opinion in Immunology, 2018
Autoinflammatory diseases are hyperinflammatory, immune dysregulatory diseases caused by innate immune cells dysregulation that present typically in the perinatal period with systemic and organ-targeted inflammation, but with improved genetic testing and the development of diagnostic criteria, milder and later-onset forms are being detected in ...
Narcisa, Martinez-Quiles, Raphaela, Goldbach-Mansky   +1 more
openaire   +2 more sources